tubular calcium reabsorption to maintain serum calcium levels within the normal range. Ligand binding to the CaSR results in conformational changes of the intracellular loops, G proteindependent stimulation of phospholipase C (PLC), causing an accumulation of inositol 1,4,5-trisphosphate (IP3) and rapid release of calcium ions from intracellular stores. The increase in intracellular calcium results in activation of protein kinase C, and CaSR also activates the mitogen-activated protein kinase (MAPK) pathway (4, 34, 36) .
A significant limitation in studies of CaSR function in the kidney has arisen from the difficulty of clearly defining the patterns of CaSR expression along the nephron. Although all studies agree that the CaSR is expressed along the basolateral membrane of the thick ascending limb of Henle (TAL), a key site of regulated calcium reabsorption (24, 35, 37) , some groups have reached different conclusions regarding the nature and level of CaSR expression in other sites. Along the nephron, Riccardi et al. (37) showed a specific receptor localization on the apical surface of the proximal tubule (PT). In contrast, Loupy et al. (24) reported that CaSR expression within the kidney is restricted to the TAL. A possible explanation for this discrepancy may be due to the use of commercial antibodies against specific fragments of the receptor. Riccardi and colleagues (8, 37, 38) , using polyclonal antibodies against both full-length CaSR and specific regions of the exofacial domains coupled with antigen retrieval, were successful in obtaining a clear apical staining of the CaSR at the base of the brush border of PT.
In the kidney, the CaSR performs different tasks depending on the various tubular segments in which it is located (3, 20, 34, 44) . In the PT, CaSR located on the apical membrane senses the increase in calcium luminal concentrations and inhibits cAMP production induced by PTH. In PTs, PTH causes phosphate excretion by internalization and degradation of phosphate reabsorption carriers in subapical vesicles derived from brush border (1, 48) . In the TAL, activation of CaSR expressed on the basolateral membrane (35) inhibits calcium paracellular reabsorption by blocking claudin-16 by activation of claudin-14 transcription (15) . In the cortical distal convoluted tubule, CaSR is expressed on the basolateral membrane, where it reduces calcium-active reabsorption, inhibiting calcium pump activity (plasma membrane Ca 2ϩ -ATPase, PMCA) (2, 13). In the collecting duct, CaSR is expressed on the apical membrane of the principal and intercalated cells (35, 45) , where, during acute vasopressin action, its activation reduces aquaporin 2 (AQP2)-mediated water reabsorption and urinary concentration (31) . CaSR has been shown also to reduce the vasopressin-induced AQP2 expression, via a calmodulin-dependent mechanism (9) .
Regarding the physiological role of CaSR expressed in the PT, recent interesting studies performed in rats and in vitro perfused mouse PTs demonstrated a role of the CaSR in enhancing proximal tubular fluid absorption and urinary acidification by stimulation of luminal Na ϩ /H ϩ exchanger (NHE) activity (10, 49) . Activation of NHE will favor the ionization of calcium so that the ionized calcium is delivered to the distal portions of the nephron, where it would be more easily reabsorbed, thus avoiding calcium precipitation along more distal segments of the nephron. Therefore, the new concept is that CaSR expressed in the PT would play an active role in modulating PT fluid absorption as well as acid secretion, and its possible involvement in prevention of renal stone disease has been postulated.
On the basis of this recent evidence, it would be interesting to clarify at the cellular level the molecular mechanism occurring in PT epithelial cells activated by increased luminal calcium concentration leading to enhanced fluid reabsorption in the PT, a process related to activation of CaSR. To this end, a cell line that would be eligible is represented by the conditionally immortalized human proximal tubular epithelial cells (ciPTEC), whose isolation from urine and immortalization has been developed by Wilmer and coworkers (53) . In recent studies, ciPTEC derived from patients were used to demonstrate the defect in Na-dependent phosphate reabsorption (52) in cystinosis and altered receptor-mediated endocytosis and the mechanisms of endosomal acidification occurring in them (16) . These cell lines therefore may represent a valuable tool for research into the disorder associated with CaSR mutations by producing cell lines from patients. ciPTEC can be maintained for at least 45 passages and present PT characteristics when cultured at the nonpermissive temperature of 37°C for 10 days (53) .
We provide here the first evidence that ciPTEC endogenously express CaSR at protein level. Moreover, exposure of ciPTEC to clinically relevant concentrations of calcium or to the positive allosteric CaSR modulator NPS-R568 resulted in an increase in intracellular calcium and a decrease of FKinduced cytosolic cAMP levels, demonstrating the expression of a functional receptor. ciPTEC could aid in understanding the role of CaSR in proton secretion and fluid reabsorption in PTs.
MATERIALS AND METHODS
Materials. All chemicals were purchased from Sigma (SigmaAldrich, Milan, Italy). Fura-2 AM was obtained from Molecular Probes (Life Technologies, Monza, Italy). NPS-R568 was kindly gifted by Amgen (Amgen Dompé, Milan, Italy). Media for cell culture were from Lonza (Lonza, Milan, Italy).
Antibodies. Monoclonal CaSR antibody recognizing amino acid 15-29 at the extracellular NH 2 terminus (17, 47) was from SigmaAldrich. To detect AQP2, we used antibodies against the 20-aminoacid residue segment just NH 2 terminal from the polyphosphorylated region of rat AQP2 (CLKGLEPDTDWEEREVRRRQ) (19, 41) . Mouse monoclonal NHE3 and rabbit anti-Na ϩ /K ϩ /2Cl Ϫ cotransporter (NKCC2) antibodies were from Chemicon (Millipore, Merck, Milan, Italy). Rabbit polyclonal anti-AQP1, mouse anti-zonula occludens 1 (ZO-1) and mouse anti-G q antibodies were obtained from Santa Cruz Biotechnologies (TebuBio, Milan, Italy). Secondary goat anti-mouse-488-conjugated antibody and streptavidin-488 conjugate were from Alexa Fluor (Molecular Probes, Eugene, OR). Secondary rabbit anti-mouse-biotin, goat anti-rabbit, and goat anti-mouse antibodies were purchased from Sigma-Aldrich.
Proximal tubular epithelial cell line generation. Primary cells were cultured as described by Wilmer and coworkers (51) by collecting midstream urine. The cell line used in this study was derived from a female healthy donor, born in 1989, who was 12 yr old when her urine was taken. Parental consent was obtained.
Urine was centrifuged (223 g, 5 min, room temperature) within 5 h after collection. After being washed in PBS and a second centrifugation step, urine sediment was resuspended in 3 ml proximal tubular epithelial cells culture medium (DMEM Ham's F12) supplemented with 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml selenium, 36 ng/ml hydrocortisone, 10 ng/ml EGF, and 40 pg/ml triiodothyronine (11) . The suspension was transferred to a 25-cm 2 tissue culture flask and placed at 37°C in a 5% CO 2 incubator. The medium was refreshed every 2-3 days (53) .
Immortalization, subcloning, and generation of ciPTEC. Primary cells were immortalized as described (53) . Briefly, cells were infected with SV40T and human telomerase reverse transcriptase vectors using the amphotropic packaging cell line PA 317 (39), containing geneticin (G418) and hygromycin resistance (30, 40) . Subconfluent cell layers were transferred to 33°C and selected by using G418 (400 g/ml) and hygromycin B (25 g/ml) for 10 days. After being cultured for 2 wk at 33°C, single-cell clones were visible and picked by using cloning discs drained in trypsin/EDTA. For the following experiments, cells were cultured at 33°C to 70% confluency, followed by maturation for 10 days at 37°C during which the cells formed a confluent monolayer. Experimental procedures were performed on the cloned cells between passages 15 and 40. Morphology of ciPTEC was evaluated by using phase-contrast microscopy.
Immunofluorescence microscopy. Immunofluorescence localization of CaSR in polarized ciPTEC was performed as previously described (22) . ciPTEC were cultured on polyester Transwell inserts and, after 10 days of maturation at 37°C, were fixed using 2% (wt/vol) paraformaldehyde in HBSS supplemented with 2% (wt/vol) sucrose for 5 min and permeabilized in 0.3% (vol/vol) Triton X-100 in HBSS for 10 min.
Cells were incubated with antibodies against the tight junction protein ZO-1 (1:200 dilution) and the CaSR (1:800 dilution) diluted in block solution containing 2% (wt/vol) BSA and 0.1% (vol/vol) Tween-20 in HBSS at 4°C overnight. Samples were treated with secondary goat-anti-mouse-Alexa 488 conjugate for ZO-1 and rabbitanti-mouse-biotin antibody followed by streptavidin-488 for CaSR and mounted on glass slides with Mowiol. Images were obtained with a confocal microscope Leica TCS SP2 (Leica Microsystems, Heerbrugg, Switzerland).
Cell preparations. ciPTEC were seeded onto 60-mm dishes and grown at 37°C for 10 days and then were lysed in cell fractionation buffer (20 mM NaCl, 130 mM KCl, 1 mM MgCl2, 10 mM Hepes, pH 7.5) in the presence of proteases (1 mM PMSF, 2 mg/ml leupeptin, and 2 mg/ml pepstatin A) and phosphatases (10 mM NaF and 1 mM sodium orthovanadate) inhibitors. Cellular debris was removed by centrifugation at 12,000 g for 20 min at 4°C. The supernatants were collected and used for immunoblotting studies.
Immunoprecipitation. For immunoprecipitation experiments, ciPTEC were seeded onto 100-mm dishes and grown at 37°C for 10 days. Immunoprecipitation experiments were performed as described (23, 42) . Briefly, ciPTEC were lysed with 1% Triton X-100, 150 mM NaCl, and 25 mM Hepes (pH 7.4) in the presence of protease inhibitors (1 mM PMSF, 2 mg/ml leupeptin, and 2 mg/ml pepstatin A). The supernatants were precleared with 50 l of immobilized protein-A and incubated overnight with anti-G␣q antibodies coupled to protein A-Sepharose. As negative control, lysates were incubated with nonspecific rabbit IgG. The immunocomplexes were washed three times, resuspended in 50 l of Laemmli buffer, and subjected to immunoblotting using CaSR antibodies.
Gel electrophoresis and immunoblotting. ciPTEC lysates were separated on 13% Bis-Tris acrylamide gels under reducing conditions. Protein bands were electrophoretically transferred onto Immobilon-P membranes (Millipore) for Western blot analysis, blocked in TBSTween-20 containing 3% BSA and incubated with primary antibodies overnight. Immunoreactive bands were detected with secondary antibody conjugated to horseradish peroxidase obtained from Santa Cruz Biotechnologies (Tebu-Bio, Milan, Italy). Membranes were developed using Super Signal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) with Chemidoc System (Bio-Rad Laboratories, Milan, Italy).
Video-imaging experiments. ciPTEC were grown on 40-mm glass coverslips at 37°C for 10 days and then were loaded with 4 M fura-2 AM for 15 min at 37°C in DMEM. Ringer's solution was used to perfuse cells during the experiment containing 120 mM NaCl, 4 mM KCl, 15 mM NaHCO 3, 1 mM MgCl2, 15 mM Hepes, 0.5 mM NaH2PO4, 10 mM glucose, 1 mM CaCl2, 0.5 mM Na2HPO4, and 0.4 mM MgSO4, pH 7.4 (modified from Refs. 25 and 26). In fluorescence measurements, the coverslips with dye-loaded cells were mounted in a perfusion chamber (FCS2 Closed Chamber System; BIOPTECHS, Butler, PA), and measurements were performed using an inverted microscope (Nikon Eclipse TE2000-S microscope) equipped for single-cell fluorescence measurements and imaging analysis. The sample was illuminated through a ϫ40 oil immersion objective (NA ϭ 1.30). The fura-2 AM-loaded sample was excited at 340 and 380 nm. Emitted fluorescence was passed through a dichroic mirror, filtered at 510 nm (Omega Optical, Brattleboro, VT), and captured by a cooled CCD camera (Cool SNAP HQ; Photometrics, Tucson, AZ). Fluorescence measurements were carried out using Metafluor software (Molecular Devices, MDS Analytical Technologies, Toronto, Ontario, Canada). The ratio of fluorescence intensities at 340 and 380 nm was plotted.
Fluorescence resonance energy transfer measurements. For evaluation of cAMP levels in ciPTEC, fluorescence resonance energy transfer (FRET) experiments were performed as described (41) . Briefly, ciPTEC were seeded onto 20-mm glass coverslips at 37°C for 10 days and transiently transfected with a plasmid (0. All treatments were performed in Ringer's solution described above, containing 1.5 mM CaCl 2. FRET measurements were carried out using MetaMorph software (Molecular Devices, MDS Analytical Technologies). Specifically, binding of cAMP to the Epac1 results in an intramolecular steric conformational modification causing an increase in the distance between the donor (CFP) and the acceptor (Venus) and a decrease of FRET process. CFP and Venus were excited at 430 and 480 nm, respectively; fluorescence emitted from CFP and Venus was measured at 480/30 and 545/35 nm, respectively. FRET from CFP to Venus was determined by excitation of CFP and measurement of fluorescence emitted from Venus. Corrected normalized FRET values were determined accordingly to Tamma (41) .
RESULTS

Characterization of ciPTEC.
Because a mixture of cell types can be exfoliated in urine, a characterization study was performed after subcloning the cell line to confirm its PT origin (12) . At 37°C, cell monolayers of the subclones expressed ZO-1 protein, indicating the epithelial origin of cells with development of tight junctions (Fig. 1) . The presence of PTspecific proteins AQP1 and NHE3 was demonstrated by immunoblotting of cells cultured for 10 days at 37°C (Fig. 2, A and B) (29) . Cells originating from other segments known to express CaSR that were contaminated were excluded by immunoblotting experiments performed using NKCC2 and AQP2 as markers of the TAL and the collecting duct, respectively. Whereas AQP2 (Fig. 2C ) and both forms of NKCC2 at 250 and 160 kDa, corresponding to the mature and the monomeric form (Fig. 2D) , were detected in mice kidney homogenate, medulla, and cortex, used as positive controls, no expression of these transporters was detected in ciPTEC lysates, confirming the purity of this cell line.
Endogenous CaSR expression in ciPTEC. We next evaluated the CaSR expression in ciPTEC by Western blotting. The monomeric form at 130 kDa, the glycosylated monomeric one at 160 kDa, and the dimeric receptor at 250 kDa were detected in ciPTEC clones grown at 37°C for 10 days as well as in HEK293 cells transfected with human CaSR, used as a positive control (Fig. 3A) . A very low expression was found in ciPTEC lysates obtained from less differentiated cells grown at 33°C (data not shown).
Immunofluorescence CaSR localization in the subconfluent monolayer of polarized ciPTEC performed after 10 days of maturation at 37°C showed a plasma membrane expression of the receptor (Fig. 3B) .
ciPTEC express functional CaSR. To evaluate whether the immunodetected CaSR protein is a functional receptor, ciPTEC were loaded with fura-2 AM (4 M) and exposed to raising concentrations of the CaSR physiological agonist, specifically to 2 mM, 5 mM, and 10 mM of extracellular calcium ( ] o , consistent with its functional expression, proving a high sensitivity of the endogenous receptor to low concentrations of its agonists. For a more specific functional analysis, cells were treated with 10 M NPS-R568, the positive allosteric CaSR modulator that increases the sensitivity of the receptor for calcium (27) . This compound is known to act selectively on the CaSR (28) . Under these conditions, a bell-shaped calcium response was observed (Fig. 4B) . Statistical analysis of the fluorescence responses revealed that cytosolic calcium levels were 46.32 Ϯ 2.28% (vs. ATP 100%, n ϭ 23) after stimulation with 2.5 M Ca 2ϩ and 37.48 Ϯ 1.71% (vs. ATP 100%, n ϭ 25) after stimulation with 10 M NPS-R568. The NPS-R568 effect was stereo selective. In fact, experiments using the S enantiomer, which is 10-to 100-fold less potent than the R enantiomers (28) , showed that in cells treated with NPS-S568 (10 M) the increase in cytosolic calcium was negligible (4.21 Ϯ 0.54% vs. ATP 100%, n ϭ 7, Fig. 4C ).
To investigate the origin of the calcium release upon specific CaSR activation with NPS-R568, calcium was depleted from the endoplasmic reticulum (ER) using 40 M cyclopiazonic acid, an inhibitor of the sarco-endoplasmatic reticulum calcium ATPasi (SERCA). Under this experimental condition, the increase in cytosolic calcium elicited by NPS-R568 was abolished, confirming that activation of CaSR results in calcium release from intracellular stores, likely the ER (Fig. 5) .
As discussed, in PT the CaSR expressed on the luminal membrane senses the increase in luminal calcium concentrations and inhibits cAMP production induced by PTH (35) . To further evaluate CaSR signaling in ciPTEC, cAMP levels were measured by FRET experiments using the H96 probe containing cAMP-binding sequence of Epac1 between CFP and Venus. Cells were treated with 10 M FK, a direct activator of adenylate cyclase, for 5 min or with the positive allosteric CaSR modulator NPS-R568, 10 M for 30 min or 20 M for 15 min, or with both NPS-R568 10 M or 20 M and FK 10 M in the last 5 min. CaSR activation with NPS-R signifi- cantly reduced FK-induced cAMP increase in a dose-dependent manner (Fig. 6) . No changes in cAMP levels were detected in NPS-R568 10 M-or 20 M-treated cells with respect to cells left under basal condition.
CaSR expressed in ciPTEC interacts with G q . The extracellular calcium-sensing receptor belongs to the C family of the G protein-coupled receptors and has been shown to couple to G q in several tissues (5, 6, 18, 50) . To evaluate whether CaSR expressed in ciPTEC is functionally coupled with G q , coimmunoprecipitation studies were performed. ciPTEC lysates were immunoprecipitated with specific anti-G q antibodies, and immunoprecipitates were next probed with anti-CaSR antibodies, revealing positive CaSR bands in all conditions corresponding to the glycosylated monomeric form at 160 kDa and the dimeric receptor at ϳ250 kDa. These studies indicate that CaSR couples with G q as a downstream effector in ciPTEC (Fig. 7) .
DISCUSSION
In this study, we provide the first evidence that ciPTEC isolated from urine of a healthy volunteer endogenously express a functional CaSR.
The immortalization of noninvasively collected cells developed by Wilmer and coworkers (53) has enabled the production of human cells maintaining PT characteristics and proliferating for at least 45 passages. For the culture of renal cells from urine, Wilmer and co-workers have used the immortalization methodology by using SV40T, originally described by Racusen and colleagues (32) . The authors have cultured ciPTEC clones from the urine of two patients with nephropathic cystinosis, an inherited disorder of PT transport attributable to lysosomal cysteine accumulation. The detailed characterization of the ciPTEC, including their viability, proliferation capacity, formation of a tight monolayer, and expression of multiple PT-specific endogenous organic ion transporters, indicates the feasibility of using urinary cells as a source for obtaining human renal material for in vitro research by collecting cells from the urine of patients (53) . Moreover, the expression pattern and the function of the majority of PT transporters were similar between cells isolated from urine compared with those isolated from kidney tissue and immortalized using the same methodology (22) .
In a very recent work, ciPTEC established from three patients affected by human Dent disease have been crucial for understanding the molecular defect in renal reabsorption, demonstrating that CLC-5 mutations have multiple effects on endosomal acidification and receptor-mediated endocytosis (14) .
The major goal of the present contribution was to evaluate and characterize ciPTEC for the functional expression of the CaSR. The availability of a human source of cells from patients affected by mutations of this receptor might be of great relevance for confirming, using a noninvasive ex vivo approach, our recent in vitro data explaining the molecular basis of gain-of-function variants of CaSR (33) . Specifically, we have shown that renal cells expressing gain-of-function CaSR variants showed a significant increase in SERCA activity and expression and a reduced PMCA expression. This combined parallel regulation increases the ER to cytosol calcium gradient, explaining the higher sensitivity of CaSR gain-of-function variants to external calcium, leading to an exacerbated signaling (33) .
In the aim of using ciPTEC obtained by immortalizing and subcloning cells exfoliated in the urine of a healthy subject as possible model systems for the study of human renal disease associated with CaSR mutations, in the present contribution, we characterized ciPTEC cells for functional CaSR expression. As a first step, cells obtained after subcloning were screened for the expression of ZO-1 of the AQP1 and NHE3 proteins, proving their epithelial and PT origin, respectively. The specific derivation of this clonal cell line from PT was demonstrated by the absence of other tubular segment protein expression such as NKCC2 and AQP2, markers of the TAL and the collecting duct, respectively.
Isolated ciPTEC expressed both the monomeric and the mature glycosylated form CaSR receptor that localized at the apical plasma membrane. Of note, functional experiments showed that activation of CaSR expressed in ciPTEC, obtained by either raising the luminal calcium ion concentration or by the specific CaSR-positive allosteric activator NPS-R568 (28), caused a release of calcium from an intracellular store likely corresponding to the ER. Functional expression of CaSR in ciPTEC was further confirmed by its ability to reduce FKinduced increase in cAMP, as it occurs in PT under PTH action.
In this work, we also evaluated G protein signaling associated with CaSR expressed in ciPTEC. The reported data obtained by coimmunoprecipitation studies identified G q as one of the possible downstream effectors of CaSR in ciPTEC.
It is known that CaSR can couple to several G proteins, such as 1) G q/11 , which stimulates PLC, thereby producing diacylglycerol and IP3, causing releases of calcium from intracellular stores; 2) G i , resulting in adenylate cyclase inhibition; and 3) G 12/13 , causing activation of Rho kinase (21, 34) . In addition to inhibiting adenylate cyclase via G i , the CaSR can also reduce cAMP indirectly by reducing the activity of calcium-sensitive adenylate cyclase or activating phosphodiesterase (14) . Our data obtained in ciPTEC indicate that the activation of CaSR expressed in PT causes an increase in intracellular calcium attributable to CaSR coupling to G q , resulting in PLC activation and IP3-dependent release in intracellular calcium. By demonstrating that human renal proximal tubular cells, ciPTEC, harbor endogenous and functional CaSR, our study provides a human cell model relevant for research into the disorder associated with gain-or loss-of-function mutations of the CaSR by producing cell lines from patients.
